KRAS and neoplasm: -Higher expression of PD-L1 in tumors harboring mutant KRAS-G12 V-Improved overall survival in KRAS mutant patients with higher expression of PD-L1 in tumor cells-Correlation between increased PD-L1 expression in immune cells and poor overall survival of KRAS-WT patients